Objective To determine whether injured patients who received a vagotomy would have worse outcomes after injury.
Design Retrospective analysis of the Nationwide Inpatient Sample (NIS) database over 10 years.
Patients Patients admitted for trauma (primary International Classification of Diseases, Ninth Revision [ICD-9 ] diagnosis codes 800-959) who had a vagotomy (ICD-9 procedure codes 44.00, 44.01, and 44.03) were included. A second cohort of injured patients without vagotomy was extracted and matched 3 to 1 on the following criteria: age, race, sex, concurrent splenectomy, survival risk ratio, payer status, comorbidities, and calendar year.
Main Outcome Measures The primary outcome measured was in-hospital mortality. Secondary outcomes included septicemia, systemic inflammatory response syndrome, acute respiratory distress syndrome, ulcer disease, length of stay, and total charges.
Results A total of 56 and 115 patients were included in the vagotomy and control groups, respectively, and were similar in demographic characteristics, comorbidities, and injury severity. We found that the vagotomy group had elevated mortality (27.27% vs 9.57% for controls; P = .003). Patients who received vagotomy also had more septicemia (26.79% vs 3.48%; P < .001) and ulcer disease (71.43% vs 2.61%; P < .001) but not systemic inflammatory response syndrome or acute respiratory distress syndrome. Patients who received vagotomy also had an increased length of hospital stay (36.4 vs 9.6 mean days; P < .001) and total cost ($211 899.90 vs $59 321.64; P < .001).
Conclusions Vagotomy after traumatic injury is associated with an increase in ulcer disease, septicemia, and mortality. This may reflect a loss of control over the systemic response to injury and warrants further study.
Multiple organ failure has been a topic of intense research for several decades and is a continuous problem in the care of critically injured patients. Multiple organ failure after injury is thought to occur when damage-associated molecular patterns are released from injured cells and bind their ligand, Toll-like receptor 4, leading to activation of NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) and increased expression of proinflammatory cytokines.1-3 When this occurs in the intestinal mucosa, it has been associated with a decrease in tight junction protein expression, resulting in breakdown of the intestinal mucosal barrier.4,5 This allows intraluminal bacteria and their products to traverse the wall of the intestine and activate inflammatory cells, leading to a massive inflammatory response, systemic cytokine expression, and ultimately, organ dysfunction and failure in tissues distant from the site of injury.6-9
Recently, the vagus nerve has been shown to have a reflexive role in modulating the proinflammatory signal produced after injury.10 The vagus nerve becomes activated, possibly by proinflammatory cytokines, and the afferent signal travels to the dorsal motor nucleus where it induces an efferent signal and the release of acetylcholine that then acts on the nicotinic α-7 receptor of macrophages and inflammatory cells.11,12 Several studies have demonstrated that blocking the nicotinic α-7 receptor leads to decreased local and systemic inflammation after injury.13,14 Our laboratory data have shown that stimulating the vagus nerve decreases inflammatory mediators in the intestine, improving intestinal barrier function and tight junction protein expression, a process that can be blocked with vagotomy.15-17 Furthermore, we have also demonstrated in an animal model that vagal activation can have consequences beyond the intestinal epithelium; vagal-stimulated animals were shown to have improved measures of lung injury and pulmonary inflammation following a severe burn.17
For many decades, truncal vagotomy with pyloroplasty or antrectomy was the standard of care for peptic ulcer disease. After the advent of proton-pump inhibitors and the discovery of Helicobacter pylori, the treatment of ulcer disease has changed dramatically and these procedures are now most often reserved for patients with a complication of their ulcer disease, such as bleeding or perforation.18 No studies have been done to evaluate the potential consequences on the inflammatory response after vagotomy in the clinical setting. Evaluating the outcomes of traumatically injured patients who receive vagotomy following their injury provides us with an interesting view into the role the vagus nerve may play in modulating systemic inflammation outside of the laboratory setting. We hypothesized that vagotomy following a traumatic injury would be associated with an increased rate of systemic inflammation, septicemia, adult respiratory distress syndrome (ARDS), and mortality.
We performed a matched case-control retrospective analysis of the Nationwide Inpatient Sample (NIS), a database sponsored by the Agency for Healthcare Research and Quality as part of the Healthcare Cost and Utilization Project, which provides a representative 20% sample of hospital discharge records from 37 states.19 We searched the most recent 10 years available, 1998 through 2007. Trauma patients 18 years or older were identified by International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes of 800 through 959 in the primary position, excluding 905 to 909 (late effects of injury), 930 to 939 (foreign body), 940 to 949 (burns), and 958 (early complications of trauma). From this cohort we identified patients who underwent vagotomy not otherwise specified, truncal vagotomy, or other selective vagotomy (ICD-9 codes 44.00, 44.01, and 44.03) during the same hospital stay. We excluded patients who underwent highly selective vagotomy, as these patients were likely to have an intact vagal connection to the small and large intestine.
A 3-to-1 matched control cohort of patients was then constructed from the same pool of patients who were admitted for the primary diagnosis of trauma identified earlier. Patients who received vagotomy were matched to the control cohort on the following criteria: age (within 10-year windows), race, sex, payer status, year of discharge, extent of injury, and presence of comorbidities. In addition, patients were matched for splenectomy performed during their hospital stay, as the spleen has been implicated in modulating the inflammatory response to injury.12,20 Matches were identical unless specified otherwise.
The data obtained from the NIS database were enriched in 2 ways. First, to estimate the extent of injury for the patients included in our study, we extracted the independent and traditional Survival Risk Ratio per International Commission on Intervention and State Sovereignty methods from the patients' available ICD-9 diagnosis codes.21 Several studies have demonstrated that the Survival Risk Ratio is an excellent estimate of the Injury Severity Score when obtaining data from administrative databases.22-24 Second, we enriched our data by calculating the comorbidities of patients using the Charlson Index per Deyo et al25 adaptation for administrative data sets.
The primary outcome variable measured was in-hospital mortality. Secondary outcomes evaluated included a concomitant diagnosis of septicemia (ICD-9 code 38), Systemic Inflammatory Response Syndrome (SIRS) or sepsis (ICD-9 code 995), ARDS (ICD-9 codes 518.82 and 518.5), and ulcer disease (ICD-9 codes 531 to 535), in addition to length of hospital stay and total charges assessed. Bivariate analysis was performed with χ2 for categorical dependent variables (death, septicemia, SIRS/sepsis, ARDS, and ulcer disease) and t tests, for continuous dependent variables (length of hospital stay and total hospital charges). Statistical analysis was performed in Stata MP 11 (StataCorp LP, College Station, Texas). Statistical significance was defined as P < .05.
A total of 3 016 627 patients who met our initial inclusion criteria were identified. Of these patients, 56 were identified as having undergone vagotomy during their hospital stay (14 patients had vagotomy not otherwise specified; 29, truncal vagotomy; and 13, other selective vagotomy). Of the patients who received vagotomy, 14 (25%) were unable to be matched on any variable to a patient in the control cohort, 4 (7.1%) were matched to only 1 control patient, and 3 (5.4%) were matched to only 2 control patients. We identified a total of 115 patients for the matched-control cohort.
There was no statistically significant difference in demographic data between the control and vagotomy cohorts (Table 1). The mean (SD) age of the controls was 56.6 (23) years vs 56.7 (22) years for the vagotomy group (P = .98). Table 2 displays the injury severity and comorbidity measures of the groups in terms of Survival Risk Ratio scores and average Charlson Index scores, which were also found to be similar. The lack of significant differences in injury severity and comorbidities between the vagotomy and control cohorts demonstrates the success of our matching.
Our primary and secondary outcome results are shown in Table 3. The vagotomy group had more in-hospital mortality, with 27.27% of patients dying vs 9.57% in the control group (P = .003). There were no differences in the rate of SIRS/sepsis or ARDS between the 2 groups; however, the vagotomy group had more septicemia than the control group (26.79% vs 3.48%; P <.001) as well as ulcer disease (71.43% vs 2.61%; P <.001). To account for the bias that may have been introduced by the uneven distribution of ulcer disease, we ran a separate analysis and matched the control cohort for incidence of ulcer diagnosis. In doing so, we were unable to match 25 (44.6%) of the patients who received vagotomy on any criteria, and the rate of ulcer diagnosis between the vagotomy and control cohorts still remained uneven (71.43% vs 50.63%; P = .02). We continued to demonstrate a significant difference in our primary outcome measure; in-hospital mortality was increased in the vagotomy group compared with controls when matched for ulcer disease (27.27% vs 3.80%; P < .001). We elected to abandon these data and proceed without matching for ulcer disease, as this matching strategy was less optimal.
Table 4 shows our additional secondary outcome data. The vagotomy group had a significantly longer hospital course (36.9 vs 9.6 days; P <.001), resulting in increased charges ($211 899.90 vs $59 321.64; P <.001). To evaluate for possible confounders contributing to our mortality results, we compiled the most frequently occurring diagnoses in the vagotomy group (data not shown). As may be expected, 44.65% of patients who received vagotomy had a diagnosis of upper gastrointestinal ulcer with hemorrhage, either duodenal or gastric.
Our study demonstrates that vagotomy performed after admission for traumatic injury is associated with a significantly increased risk of in-hospital mortality and septicemia, resulting in increased length of stay and hospital charges. Using a retrospective review of a national sample of inpatients, we demonstrated that patients who underwent vagotomy following admission for traumatic injuries had a nearly 3-fold increased risk of in-hospital mortality. Septicemia in these patients was also significantly increased, more than 8 times the rate seen in control patients.
The increased incidence of ulcer disease among patients who received vagotomy that was seen in our study likely reflects the reason for undergoing vagotomy and may be a manifestation of their physiologic derangement. It is possible that the mortality differences seen in our study are a consequence of ulcer disease and its complications, such as hemorrhage and perforation, independent of the vagotomy procedure. We feel that this is unlikely, as our efforts to account for this and match the groups for ulcer disease still resulted in significantly increased mortality in the vagotomy group.
Our study is not without several significant limitations. Our use of the NIS database, an administrative database sampling a large percentage of inpatient admissions, allowed us to identify an infrequently occurring patient population—patients undergoing vagotomy after traumatic injury—to understand how the anti-inflammatory reflex pathway may be involved in postinjury systemic inflammation. However, the NIS database does not provide information on the timing of procedures or diagnoses made during the hospitalization.19 This is an important limitation for our study because we cannot definitively conclude that the increased mortality or septicemia found in our study occurred as a direct result of the vagotomy procedure since we do not know the chronological order of events. Furthermore, the NIS database does not contain physiologic data, and we are unable to determine the extent of physiologic abnormalities that occurred in the patients included in our study. Lastly, the NIS database does not provide any information on the medical histories of patients prior to their current hospitalization, which might enlighten our understanding of their risks further.
That said, we have shown that patients who undergo a vagotomy during the immediate postinjury period have worse outcomes, possibly by limiting the protection offered by an intact vagus nerve to the gut mucosa or its overall attenuation of the inflammatory response. This is in concordance with the animal data reported by our laboratory and others.10,13-15 Using a model of severe cutaneous burn, we have shown that animals who had stimulation of the vagus nerve, both before and after injury, have preservation of the intestinal villi and gut tight junction proteins, resulting in decreased intestinal permeability to intraluminal contents.16 When the vagus nerve was severed prior to stimulation, the intestinal permeability and levels of tight junction proteins were disrupted and shown to be similar to the burn injury group.16,17 Our laboratory has shown a protective effect of vagal stimulation up to 90 minutes following injury, providing a potential therapeutic window during which intestinal inflammation can be modulated.17
The mechanism of the anti-inflammatory pathway has yet to be fully elucidated. Huston et al13 demonstrated, using an endotoxemia model, that vagal stimulation in animals that received splenectomy failed to decrease serum levels of tumor necrosis factor beyond splenectomy alone. On the contrary, work in our laboratory has shown that intestinal permeability following burn injury in rodents without the spleen was improved with vagal stimulation and returned to levels similar to those in sham animals, whereas animals that receive splenectomy alone had significant barrier breakdown following burn injury.16 Our findings suggest that the vagus nerve's preservation of the intestinal barrier after burn injury has a component that is independent of the spleen. For the purposes of our current study, we elected to match patients for splenectomy owing to the potential infectious complications that may arise in the later postoperative period, thereby controlling for a potential source of bias.
An interesting finding in this study is the lack of difference in SIRS and ARDS between the vagotomy and control groups. Given our laboratory research, which has demonstrated a lung protective effect of vagal stimulation, we hypothesized that the vagotomy group would have a higher rate of ARDS and systemic SIRS. This result may be owing to our small sample size and the relatively low incidence of documented SIRS in both groups. However, our experimental data show that an abdominal vagotomy abolishes the protective effects of vagus nerve stimulation in the lung, confirming the importance of an “impermeable” intestinal barrier in the prevention of acute lung injury in our model.17
There is a considerable amount of research yet to be conducted on the intricacies of the vagal nerve and the anti-inflammatory response. Future animal study is needed to determine the mechanism as well as important cell types and signaling molecules. In addition, the development of a vagomimetic drug candidate to activate the anti-inflammatory response may be an important advance and is currently an ongoing project in our laboratory. Prospective clinical research evaluating patients who receive a vagal stimulus is needed and may provide more definitive answers. Ultimately, vagal stimulation may provide clinicians with a therapy that can be easily applied after injury to ameliorate systemic inflammation and could potentially save an untold number of lives.
We have shown that patients admitted for traumatic injuries who undergo vagotomy during hospitalization have increased mortality and rate of septicemia compared with matched control patients without vagotomy. This supports our hypothesis that the vagus nerve may be implicated in the systemic inflammatory response, and vagal activation can act as an anti-inflammatory modulator.
Accepted for Publication: April 11, 2011.
Published Online: September 19, 2011. doi:10.1001 /archsurg.2011.237
Correspondence: David C. Chang, MBA, MPH, PhD, Department of Surgery, University of California, San Diego, 200 W Arbor Dr, Ste 8401, San Diego, CA 92103-8401 (firstname.lastname@example.org).
Author Contributions: Dr Chang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Peterson, Krzyzaniak, and Coimbra. Acquisition of data: Peterson and Chang. Analysis and interpretation of data: Peterson, Coimbra, and Chang. Drafting of the manuscript: Peterson. Critical revision of the manuscript for important intellectual content: Krzyzaniak, Coimbra, and Chang. Statistical analysis: Chang. Administrative, technical, and material support: Coimbra and Chang. Study supervision: Coimbra and Chang.
Financial Disclosure: None reported.
Funding/Support: Funding for this study is departmental.
Previous Presentations: This paper was presented at the 82nd Annual Meeting of the Pacific Coast Surgical Association; February 19, 2011; Scottsdale, Arizona, and is published after peer review and revision.
Additional Contributions: We thank Hayley B. Osen, BA, University of California, San Diego, for help in revising and editing this manuscript.
Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock
. 2006;26(5):430-43717047512PubMedGoogle ScholarCrossref
Fan J, Li Y, Levy RM,
et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol
. 2007;178(10):6573-658017475888PubMedGoogle Scholar
Gribar SC, Richardson WM, Sodhi CP, Hackam DJ. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med
. 2008;14(9-10):645-65918584047PubMedGoogle Scholar
Peterson CY, Costantini TW, Loomis WH,
et al. Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury. Surg Infect (Larchmt)
. 2010;11(2):137-14420374005PubMedGoogle Scholar
Costantini TW, Loomis WH, Putnam JG,
et al. Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock
. 2009;31(4):416-42218791495PubMedGoogle Scholar
Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil
. 2005;26(5):383-39116151282PubMedGoogle Scholar
Sambol JT, Xu DZ, Adams CA, Magnotti LJ, Deitch EA. Mesenteric lymph duct ligation provides long term protection against hemorrhagic shock-induced lung injury. Shock
. 2000;14(3):416-42011028566PubMedGoogle Scholar
Anjaria DJ, Rameshwar P, Deitch EA,
et al. Hematopoietic failure after hemorrhagic shock is mediated partially through mesenteric lymph. Crit Care Med
. 2001;29(9):1780-178511546985PubMedGoogle Scholar
Sambol JT, White J, Horton JW, Deitch EA. Burn-induced impairment of cardiac contractile function is due to gut-derived factors transported in mesenteric lymph. Shock
. 2002;18(3):272-27612353930PubMedGoogle Scholar
Bernik TR, Friedman SG, Ochani M,
et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg
. 2002;36(6):1231-123612469056PubMedGoogle Scholar
Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest
. 2007;117(2):289-29617273548PubMedGoogle Scholar
Huston JM, Ochani M, Rosas-Ballina M,
et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med
. 2006;203(7):1623-162816785311PubMedGoogle Scholar
de Jonge WJ, van der Zanden EP, The FO,
et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol
. 2005;6(8):844-85116025117PubMedGoogle Scholar
Costantini TW, Bansal V, Peterson CY,
et al. Efferent vagal nerve stimulation attenuates gut barrier injury after burn: modulation of intestinal occludin expression. J Trauma
. 2010;68(6):1349-135620539179PubMedGoogle Scholar
Costantini TW, Bansal V, Krzyzaniak M,
et al. Vagal nerve stimulation protects against burn-induced intestinal injury through activation of enteric glia cells. Am J Physiol Gastrointest Liver Physiol
. 2010;299(6):G1308-G131820705905PubMedGoogle Scholar
Krzyzaniak MJ, Peterson CY, Cheadle G,
et al. Efferent vagal nerve stimulation attenuates acute lung injury following burn: the importance of the gut-lung axis. SurgeryIn pressGoogle Scholar
Donahue PE. Parietal cell vagotomy versus vagotomy-antrectomy: ulcer surgery in the modern era. World J Surg
. 2000;24(3):264-26910658059PubMedGoogle Scholar
Huston JM, Wang H, Ochani M,
et al. Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels. J Immunol
. 2008;181(5):3535-353918714026PubMedGoogle Scholar
Osler T, Rutledge R, Deis J, Bedrick E. ICISS: an international classification of disease-9 based injury severity score. J Trauma
. 1996;41(3):380-3888810953PubMedGoogle Scholar
Rutledge R, Hoyt DB, Eastman AB,
et al. Comparison of the Injury Severity Score and ICD-9
diagnosis codes as predictors of outcome in injury: analysis of 44,032 patients. J Trauma
. 1997;42(3):477-4899095116PubMedGoogle Scholar
Meredith JW, Kilgo PD, Osler TM. Independently derived survival risk ratios yield better estimates of survival than traditional survival risk ratios when using the ICISS. J Trauma
. 2003;55(5):933-93814608168PubMedGoogle Scholar
Hannan EL, Farrell LS. Predicting trauma inpatient mortality in an administrative database: an investigation of survival risk ratios using New York data. J Trauma
. 2007;62(4):964-96817426555PubMedGoogle Scholar
Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM
administrative data: differing perspectives. J Clin Epidemiol
. 1993;46(10):1075-10798410092PubMedGoogle Scholar